PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Insulin resistance is a major hallmark in the development of type 2 diabetes, which is characterized by an impaired ability of insulin to inhibit glucose output from the liver and to promote glucose uptake in muscle. The nuclear hormone receptor coactivator PGC-1 (peroxisome proliferator-activated (PPAR)-gamma coactivator-1) has been implicated in the onset of type 2 diabetes. Hepatic PGC-1 expression is elevated in mouse models of this disease, where it promotes constitutive activation of gluconeogenesis and fatty acid oxidation through its association with the nuclear hormone receptors HNF-4 and PPAR-alpha, respectively. Here we show that PGC-1-deficient mice, generated by adenoviral delivery of PGC-1 RNA interference (RNAi) to the liver, experience fasting hypoglycemia. Hepatic insulin sensitivity was enhanced in PGC-1-deficient mice, reflecting in part the reduced expression of the mammalian tribbles homolog TRB-3, a fasting-inducible inhibitor of the serine-threonine kinase Akt/PKB (ref. 6). We show here that, in the liver, TRB-3 is a target for PPAR-alpha. Knockdown of hepatic TRB-3 expression improved glucose tolerance, whereas hepatic overexpression of TRB-3 reversed the insulin-sensitive phenotype of PGC-1-deficient mice. These results indicate a link between nuclear hormone receptor and insulin signaling pathways, and suggest a potential role for TRB-3 inhibitors in the treatment of type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PGC-1α is elevated in liver in mouse models of diabetes and regulates the expression of TRB3, an inhibitor of insulin-dependent AKT activation [87, 88].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [88]
Citations
Cites
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326 · cited 1×
“jpg" NDATA ITEM> ]> Insulin resistance is a major hallmark in the development of type 2 diabetes, which is characterized by an impaired ability of insulin to inhibit glucose output from the liver and to promote glucose uptake in muscl”
BackgroundWu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139 · cited 1×
“Despite its importance in promoting mitochondrial function in skeletal muscl”
BackgroundCho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,836
Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821
Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting
Kersten, S., Seydoux, J., Peters, J. M., Gonzalez, F. J., Desvergne, B., & Wahli, W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6223 · Cited by 1,649 · cited 1×
“The hypoglycemic fatty liver phenotype in PGC-1 knockdown mice is reminiscent of the phenotype of PPAR-α-deficient mice, which have hepatic steatosis and hypoglycemi”
BackgroundCREB regulates hepatic gluconeogenesis through the coactivator PGC-1
Herzig, S., Long, F., Jhala, U. S., Hedrick, S., Quinn, R., Bauer, A., Rudolph, D., Schutz, G., Yoon, C., Puigserver, P., et al. (2001) · Nature · doi:10.1038/35093131 · Cited by 1,440
Self-citationKliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., Umesono, K., & Evans, R. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7355 · Cited by 1,400 · cited 1×
“Overexpression of PPAR-α and its heterodimeric partner RX”
BackgroundSelf-citationDresner, A., Laurent, D., Marcucci, M., Griffin, M. E., Dufour, S., Cline, G. W., Slezak, L. A., Andersen, D. K., Hundal, R. S., Rothman, D. L., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5001 · Cited by 1,311 · cited 1×
“Free fatty acids are thought to inhibit glucose us”
BackgroundMichael, M. D., Kulkarni, R. N., Postic, C., Previs, S. F., Shulman, G. I., Magnuson, M. A., & Kahn, C. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00015-8 · Cited by 1,296 · cited 1×
“Both TRB-3 mRNA and PGC-1 mRNA were elevated in LIRKO mice, which have a knockout of the insulin receptor in live”
BackgroundSelf-citationTen years of protein kinase B signalling: a hard Akt to follow
Brazil, D. P., & Hemmings, B. A. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01958-2 · Cited by 1,177 · cited 1×
“In the fed state, insulin inhibits hepatic glucose output through a cascade of phospholipid-dependent kinases that activate Akt/PKB by phosphorylating it at Thr308 and Ser473 (refs”
Background
Cited by
Items 301–400 of 552
Kim, D., & Park, S. H. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.05.046 · Cited by 40
Hosono, T., Mizuguchi, H., Katayama, K., Koizumi, N., Kawabata, K., Yamaguchi, T., Nakagawa, S., Watanabe, Y., Mayumi, T., & Hayakawa, T. (2005) · Gene · doi:10.1016/j.gene.2005.01.005 · Cited by 43
Ezrokhi, M., Luo, S., Trubitsyna, Y., & Cincotta, A. H. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-104 · Cited by 42
Li, L., Zhang, P., Bao, Z., Wang, T., Liu, S., & Huang, F. (2016) · Scientific Reports · doi:10.1038/srep24156 · Cited by 42
de Souza, C. T., ARAUJO, E. P. D., Prada, P. O., Saad, M. J. A., Boschero, A. C., & Velloso, L. A. (2005) · Diabetologia · doi:10.1007/s00125-005-1866-4 · Cited by 49
“As a transcriptional coactivator, PGC1α has several functional domains that participate in protein–protein interaction with PPARγ [5], PPARα [6], nuclear respiratory factor [7], cyclic AMP response element binding protein (CREB)-binding protein [8], hepatocyte nuclear factor-4α (HNF-4α) [9, 10], forkhead transcription…”
BackgroundTribbles: ‘puzzling’ regulators of cell signalling
Kiss‐Toth, E. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390684 · Cited by 40
Genetic models of PGC-1 and glucose metabolism and homeostasis
Rowe, G. C., & Arany, Z. P. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9273-5 · Cited by 43
“Early in vivo experiments, using primarily adenoviral delivery to the liver of PGC-1α or si-PGC-1α, showed that PGC-1α activates gluconeogenesis by inducing the expression of gluconeogenic enzymes, including phosphoenolpyruvate carboxykinase (PEPCK) and glucose 6-phosphatase (G-6Pase) [6, 57]).”
BackgroundMisra, J., Kim, D., Jung, Y. S., Kim, H. B., Kim, Y., Yoo, E.-K., Kim, B. G., Kim, S., Lee, I., Harris, R. A., et al. (2016) · Diabetes · doi:10.2337/db15-1523 · Cited by 39
Self-citationPotential regulatory role of the farnesoid X receptor in the metabolic syndrome
Durán-Sandoval, D., Cariou, B., Fruchart, J., & Staels, B. (2004) · Biochimie · doi:10.1016/j.biochi.2004.11.018 · Cited by 42
Ohashi, N., Morino, K., Ida, S., Sekine, O., Lemecha, M., Kume, S., Park, S., Choi, C. S., Ugi, S., & Maegawa, H. (2017) · Diabetes · doi:10.2337/db16-1427 · Cited by 38
cAMP-inducible coactivator CRTC3 attenuates brown adipose tissue thermogenesis
Yoon, Y., Tsai, W., de Velde, S. V., Chen, Z., Lee, K., Morgan, D. A., Rahmouni, K., Matsumura, S., Wiater, E., Song, Y., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1805257115 · Cited by 36
Self-citationBanerjee, S., Ghoshal, S., Stevens, J. R., McCommis, K. S., Gao, S., Castro‐Sepúlveda, M., Mizgier, M. L., Clemence, G., Kumar, K. G., Galgani, J. E., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.014381 · Cited by 38
“Conversely, suppression of PGC1A in the liver using RNAi results in fasting hypoglycemia (76).”
BackgroundThe immune response as a therapeutic target in non-alcoholic fatty liver disease
Ortiz‐López, N., Fuenzalida, C., Dufeu, M. S., Pinto-León, A., Escobar, A. F., Poníachik, J., Roblero, J. P., Valenzuela-Pérez, L., & Beltrán, C. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.954869 · Cited by 40
“Based on these mechanisms, PPARa regulates the hepatic metabolism of fats (73) and glucose (74).”
BackgroundÖrd, T., Örd, D., Kõivomägi, M., Juhkam, K., & Örd, T. (2009) · Gene · doi:10.1016/j.gene.2009.06.001 · Cited by 36
Li, Y., Nara, T., & Nakamura, M. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500237-jlr200 · Cited by 42
Amelioration of glucose tolerance by hepatic inhibition of nuclear factor κB in db/db mice
Tamura, Y., Ogihara, T., Uchida, T., Ikeda, F., Kumashiro, N., Nomiyama, T., Sato, F., Hirose, T., Tanaka, Y., Mochizuki, H., et al. (2006) · Diabetologia · doi:10.1007/s00125-006-0467-1 · Cited by 39
“Furthermore, in non-diabetic rodents, inhibition of PGC-1α lowered hepatic glucose output together with reduction of PEPCK and G6Pase expression levels [36].”
BackgroundH. Swerdlow, R. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798072535 · Cited by 35
“Silent information regulator 1 (SIRT1), AMP kinase (AMPK), cyclic AMP responsive element binding protein (CREB), mTOR, the forkhead transcription factors (FOXOs), and AKT all associate with PGC1a in that they either directly or indirectly influence or are influenced by PGC1a [211, 212, 213, 214, 215, 216, 217, 218, 21…”
BackgroundShen, Z., Liu, C., Liu, P., Zhao, J., & Xu, W. (2013) · Cell Stress and Chaperones · doi:10.1007/s12192-013-0480-5 · Cited by 37
Evaluation of Plasma TRB3 and Sestrin 2 Levels in Obese and Normal-Weight Children
Nourbakhsh, M., Sharifi, R., Ghorbanhosseini, S. S., Javad, A., Ahmadpour, F., Azar, M. R., & Larijani, B. A. (2017) · Childhood Obesity · doi:10.1089/chi.2017.0082 · Cited by 36
“Based on HOMA-IR, 15.5% ( n = 11) of obese subjects had IR.”
InfluentialXu, Y., Luo, Z., Wu, K., Fan, Y.-F., You, W., & Zhang, L.-H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112405 · Cited by 35
“For instance, studies suggested that PPARα-induced activation of CP Iα gene was enhanced in a ligand-dependent manner by PGC-1 [46], and PGC-1, as a co-activator, can activate gene transcription through HNF4α [47].”
BackgroundSepa-Kishi, D. M., Katsnelson, G., Bikopoulos, G. J., Iqbal, A., & Ceddia, R. B. (2018) · Physiological Reports · doi:10.14814/phy2.13592 · Cited by 37
Matos, A., Ropelle, E. R., Pauli, J. R., Frederico, M. J. S., Pinho, R. A., Velloso, L. A., & de Souza, C. T. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.02031.x · Cited by 41
“In addition, overexpression of TRB3 decreases, and knockdown of TRB3 expression increases Akt activation by insulin in the liver and muscle (Koo et al. 2004, Matsushima et al. 2006, Hegedus et al. 2007).”
BackgroundAncient Wheat Diet Delays Diabetes Development in a Type 2 Diabetes Animal Model
Thorup, A. C. S., Gregersen, S., & Jeppesen, P. B. (2014) · The Review of Diabetic Studies · doi:10.1900/rds.2014.11.245 · Cited by 37
A postnatal molecular switch drives activity-dependent maturation of parvalbumin interneurons
Moissidis, M., Abbasova, L., Selten, M. M., Alis, R., Bernard, C., Domínguez-Canterla, Y., Oozeer, F., Qin, S., Kelly, A., Mòdol, L., et al. (2025) · Cell · doi:10.1016/j.cell.2025.06.029 · Cited by 43
Energy dysfunction in Huntington’s disease: insights from PGC-1α, AMPK, and CKB
Ju, T., Lin, Y., & Chern, Y. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1025-2 · Cited by 42
“Moreover, PPARa promotes insulin resistance in the liver [60].”
BackgroundHS218 as an FXR antagonist suppresses gluconeogenesis by inhibiting FXR binding to PGC-1α promoter
Xu, X., Shi, X., Chen, Y., Zhou, T., Wang, J., Xu, X. Y., Chen, L., Hu, L., & Shen, X. (2018) · Metabolism · doi:10.1016/j.metabol.2018.03.016 · Cited by 34
Lee, J.-M., Han, H.-S., Jung, Y. S., Harris, R. A., Koo, S., & Choi, H. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002196 · Cited by 35
Self-citationChoi, Y., Bose, S., Shin, N. R., Song, E., Nam, Y., & Kim, H. (2020) · Nutrients · doi:10.3390/nu12020276 · Cited by 34
Nourbakhsh, M., Sharifi, R., Heydari, N., Nourbakhsh, M., Ezzati‐Mobaser, S., & Zarrinnahad, H. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01683-5 · Cited by 38
Marinho, R., Mekary, R. A., Muñoz, V. R., Gomes, R. J., Pauli, J. R., & de Moura, L. P. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0064-x · Cited by 35
“The effects of TRB3 in the organism remain unclear; for instance, TRB3 can have positive effects in the adipocytes because it can increase fatty acid oxidation [35]; conversely, TRB3—induced by ER stress—can have negative effects in the liver because it can decrease insulin signaling by binding to Akt and inhibiting i…”
BackgroundAdiponectin and thiazolidinedione targets CRTC2 to regulate hepatic gluconeogenesis
Yoon, Y.-S., Ryu, D., Lee, M., Hong, S., & Koo, S. (2009) · Experimental & Molecular Medicine · doi:10.3858/emm.2009.41.8.063 · Cited by 34
“Western blot analysis using 50-100 μg of protein from whole cell lysates were performed as described previously (Koo et al., 2004).”
MethodSelf-citationWhite, H. M., Koser, S. L., & Donkin, S. S. (2011) · Journal of Dairy Science · doi:10.3168/jds.2010-3960 · Cited by 33
“The PPARα agonist Wy14643 has previously been used in cell culture experiments at concentrations rang- Journal of Dairy Science Vol. 94 No. 7, 2011 ing from 0.05 to 150 μM (Koo et al., 2004; Thering et al., 2009).”
MethodInfluentialMolecular Approaches to Study Control of Glucose Homeostasis
Neubauer, N., & Kulkarni, R. N. (2006) · ILAR Journal · doi:10.1093/ilar.47.3.199 · Cited by 37
“Adeno- virus-mediated depletion of PGC-1 in the liver confirmed an important role for the coactivator in regulating gluconeogenesis and insulin sensitivity of the liver (Koo et al. 2004).”
BackgroundSelf-citationTavares, C. D. J., Aigner, S., Sharabi, K., Sathe, S., Mutlu, B., Yeo, G. W.-M., & Puigserver, P. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2000643117 · Cited by 33
Insulin Regulates TRB3 and Other Stress-Responsive Gene Expression through Induction of C/EBPβ
Du, K., & Ding, J. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0284 · Cited by 36
Mitochondria and diabetes mellitus: untangling a conflictive relationship?
Schiff, M., Loublier, S., Coulibaly, A., Bénit, P., Ogier de Baulny, H., & Rustin, P. (2009) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-009-1263-0 · Cited by 34
“In humans with T2D, the ability of insulin to inhibit hepatic gluconeogenesis is impaired (Petersen and Shulman 2006); and in T2D animal models, liver PGC-1a expression is elevated (Herzig et al. 2001; Koo et al. 2004; Saltiel and Kahn 2001; Yoon et al. 2001).”
BackgroundSweeney, T. E., Suliman, H. B., Hollingsworth, J. W., Welty‐Wolf, K. E., & Piantadosi, C. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025249 · Cited by 32
“PGC-1 is also critically involved in lipid homeostasis and glucose metabolism [27,28], especially in the liver, wherein heterozygosity of PGC-1a reduces”
BackgroundOverexpression of TRB3 Gene in Adipose Tissue of Rats with High Fructose-induced Metabolic Syndrome
Bi, X., Tan, H., Xing, S., Wang, Z., Tang, M., Zhang, Y., & Zhang, W. (2008) · Endocrine Journal · doi:10.1507/endocrj.k08e-049 · Cited by 31
Similar metabolic responses to calorie restriction in lean and obese Zucker rats
Chiba, T., Komatsu, T., Nakayama, M., Adachi, T., Tamashiro, Y., Hayashi, H., Yamaza, H., Higami, Y., & Shimokawa, I. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.05.001 · Cited by 34
Goyenechea, E., Crujeiras, A. B., Abete, I., Parra, D., & Martínez, J. A. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.08.011 · Cited by 32
“[35] S.”
BackgroundFan, Y., Guo, Y., Hamblin, M., Chang, L., Zhang, J., & Chen, Y. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.232918 · Cited by 42
Lin, K.-R., Lee, S.-F., Hung, C., Li, C., Yang‐Yen, H., & Yen, J. J. Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701663200 · Cited by 30
Xu, M. J., Lu, N., Sun, Z., Zhang, H., Dai, Q., Wei, L., Li, Z., You, Q., & Guo, Q. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.05.008 · Cited by 31
Glucagon-Induced Acetylation of Energy-Sensing Factors in Control of Hepatic Metabolism
Zhang, L., Yao, W., Xia, J., Wang, T., & Huang, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081885 · Cited by 32
Parvaiz, F., Manzoor, S., Iqbal, J., McRae, S., Javed, F., Ahmed, Q. L., & Waris, G. (2013) · Archives of Virology · doi:10.1007/s00705-013-1892-3 · Cited by 29
PI3K activates negative and positive signals to regulate TRB3 expression in hepatic cells
Ding, J., Kato, S., & Du, K. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.01.026 · Cited by 29
Nagahara, Y., Shimazawa, M., Tanaka, H., Ono, Y., Noda, Y., Ohuchi, K., Tsuruma, K., Katsuno, M., Sobue, G., & Hara, H. (2015) · Journal of Neuroscience Research · doi:10.1002/jnr.23619 · Cited by 29
“…line-derived neurotrophic factor (Li et al., 2007), and heat shock protein 70 (Gifondorwa et al., 2007, 2012) protect against ALS in SOD1G93A mice by acting on hind-limb skeletal muscle; however, they also cause side effects, such as insulin resistance (Koo et al., 2004).”
BackgroundRole of BAF60a/BAF60c in chromatin remodeling and hepatic lipid metabolism
Zhang, P., Li, L., Bao, Z., & Huang, F. (2016) · Nutrition & Metabolism · doi:10.1186/s12986-016-0090-1 · Cited by 30
Mitochondria in response to nutrients and nutrient-sensitive pathways
Baltzer, C., Tiefenböck, S. K., & Frei, C. (2010) · Mitochondrion · doi:10.1016/j.mito.2010.07.009 · Cited by 34
“Similar to the fly data, some studies have shown a requirement of PGC-1s for insulin signalling (Vianna et al., 2006; Pagel-Langenickel et al., 2008), whereas an inhibitory function of PGC-1α on insulin signalling has also been observed (Koo et al., 2004; Choi et al., 2008).”
ResultAcute Exercise Decreases Tribbles Homolog 3 Protein Levels in the Hypothalamus of Obese Rats
Rodrigues, B. D. A., Pauli, L. S. S., de Souza, C. T., da Silva, A. S. R., Cintra, D. E., Marinho, R., de Moura, L. P., Ropelle, E. C. C., Botezelli, J. D., Ropelle, E. R., et al. (2014) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000000585 · Cited by 32
Li, Y., Lou, N., Liu, X., Zhuang, X., & Chen, S. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116755 · Cited by 29
Mukherjee, S., Basar, M. A., Davis, C. P., & Duttaroy, A. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00216 · Cited by 27
“Therefore liver-specific knock down of PGC-1 shows higher insulin sensitivity in mice (Koo et al., 2004).”
BackgroundMagnoliaExtract (BL153) Ameliorates Kidney Damage in a High Fat Diet-Induced Obesity Mouse Model
Cui, W., Wang, Y., Chen, Q., Sun, W., Cai, L., Tan, Y., Kim, K.-S., Kim, K. H., & Kim, Y. H. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/367040 · Cited by 28
Therapeutic Potential of RNAi in Metabolic Diseases
Rondinone, C. M. (2006) · BioTechniques · doi:10.2144/000112163 · Cited by 30
Snf1-related kinase improves cardiac mitochondrial efficiency and decreases mitochondrial uncoupling
Rines, A. K., Chang, H., Wu, R., Sato, T., Khechaduri, A., Kouzu, H., Shapiro, J. S., Shang, M., Burke, M. A., Abdelwahid, E., et al. (2017) · Nature Communications · doi:10.1038/ncomms14095 · Cited by 26
MicroRNA-124 promotes hepatic triglyceride accumulation through targeting tribbles homolog 3
Liu, X., Zhao, J., Liu, Q., Xiong, X., Zhang, Z., Jiao, Y., Li, X., Liu, B., Li, Y., & Lu, Y. (2016) · Scientific Reports · doi:10.1038/srep37170 · Cited by 25
“Besides, specific overexpression or knockdown of TRB3 in livers promoted or improved insulin resistance, respectively 34,35 .”
Overexpression of TRB3 in muscle alters muscle fiber type and improves exercise capacity in mice
An, D., Lessard, S. J., Toyoda, T., Lee, M.-Y., Koh, H.-J., Qi, L., Hirshman, M. F., & Goodyear, L. J. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00027.2014 · Cited by 31
Fasting induced up-regulation of activating transcription factor 5 in mouse liver
Shimizu, Y. I., Morita, M., Ohmi, A., Aoyagi, S., Ebihara, H., Tonaki, D., Horino, Y., Iijima, M., Hirose, H., Takahashi, S., et al. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.04.002 · Cited by 27
Qi, Y., Yin, X. L., Wang, S., Jiang, H., Wang, X., Ren, M., Su, X.-P., Shi, L., & Feng, H. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00204 · Cited by 26
“The shRNA targeting 5′-GGTGGATTGAAGTGGTGTAGA-3’ within mouse PGC-1α coding sequence (Koo et al., 2004) was designed and cloned into pLL3.”
HSDL2 links nutritional cues to bile acid and cholesterol homeostasis
Samson, N., Bosoi, C. R., Roy, C., Turcotte, L., Tribouillard, L., Mouchiroud, M., Berthiaume, L., Trottier, J., Silva, H. C. G., Guerbette, T., et al. (2024) · Science Advances · doi:10.1126/sciadv.adk9681 · Cited by 24
Cunard, R. A. (2013) · Scientifica · doi:10.1155/2013/750871 · Cited by 27
Application of serial analysis of gene expression to the study of human genetic disease
Horan, M. P. (2009) · Human Genetics · doi:10.1007/s00439-009-0719-5 · Cited by 23
“These data are in agreement with previous reports on diabetic animal models which demonstrated elevated expression of PGC-1 in the livers of these animals (Yoon et al. 2001; Saltiel and Kahn 2001; Herzig et al. 2001; Koo et al. 2004).”
ResultZhu, G., Ueda, K., Hashimoto, M., Zhang, M., Sasaki, M., Kariya, T., Sasaki, H., Kaludercic, N., Lee, D., Bedja, D., et al. (2021) · FEBS Letters · doi:10.1002/1873-3468.14228 · Cited by 24
Loss of TRIM67 Attenuates the Progress of Obesity-Induced Non-Alcoholic Fatty Liver Disease
Huang, C., Wei, X., Luo, Q., Xia, Y., Pan, T. S., He, J., Jahangir, A., Jia, L., Liu, W., Zou, Y., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137475 · Cited by 24
“Peroxisome proliferator-activated receptor-γ coativator-1α (PGC-1α) interacts with multiple nuclear or non-nuclear receptors or transcriptional factors to regulate mitochondrial biogenesis, respiration, hepatic gluconeogenesis and lipid metabolism [37,38].”
BackgroundThe tribbles gene family and lipoprotein metabolism
Angyal, A., & Kiss‐Toth, E. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283508c3b · Cited by 25
Neels, J. G., & Olefsky, J. M. (2006) · Science · doi:10.1126/science.1130476 · Cited by 22
Self-citationMoazzami, A. A., Frank, S., Gombert, A., Sus, N., Bayram, B., Rimbach, G. H., & Frank, J. (2015) · Food & Function · doi:10.1039/c4fo00947a · Cited by 23
SRY-Box Containing Gene 4 Promotes Liver Steatosis by Upregulation of SREBP-1c
Jiao, Y., Zhao, J., Zhang, Z., Li, M., Xi, Y., Yang, Y., Liu, J., Liao, S., Li, D., Wang, Y., et al. (2018) · Diabetes · doi:10.2337/db18-0184 · Cited by 24
Jo, D., Yoon, G., & Song, J. (2021) · Antioxidants · doi:10.3390/antiox10010078 · Cited by 25
Ma, D., Shuler, J. M., Raider, K. D., Rogers, R. S., Wheatley, J. L., Geiger, P. C., & Stanford, J. A. (2015) · Brain Research · doi:10.1016/j.brainres.2015.03.053 · Cited by 21
“Its expression is downregulated in skeletal muscles of insulin resistant and T2D subjects (Canto and Auwerx, 2009), but upregulated in liver tissue from diabetic mice (Puigserver et al., 2003, Koo et al., 2004).”
BackgroundOntogeny of Hepatic Energy Metabolism Genes in Mice as Revealed by RNA-Sequencing
Renaud, H. J., Cui, Y. J., Lü, H., Zhong, X., & Klaassen, C. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104560 · Cited by 21
“PGC-1a (Ppargc1a) and Ppara are transcription factors known to regulate these pathways in adults [14,15,16]; however, Yubero et al.”
BackgroundWang, C., Li, Z., Zhao, B., Wu, Y., Fu, Y., Kang, K., Li, Y., Dong, L., Li, X., Zhang, B., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6677955 · Cited by 21
Gene program-specific regulation of PGC-1α activity
Schmidt, S. F., & Mandrup, S. (2011) · Genes & Development · doi:10.1101/gad.2076411 · Cited by 24
Santamarina, A. B., de Moraes, R. C. M., Filho, V. N., Murata, G. M., de Freitas, J. A., de Miranda, D. A., Cerqueira, A., Costa, S. K. P., Ferreira, A. F. F., Britto, L. R., et al. (2022) · Antioxidants · doi:10.3390/antiox11030447 · Cited by 23
“This is probably by fatty acid oxidation enzymes and gluconeogenesis decrease [86].”
BackgroundMisra, J., Chanda, D., Kim, D.-K., Cho, S.-R., Koo, S., Lee, C. H., Back, S. H., & Choi, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086342 · Cited by 21
Self-citationGluconeogenesis, lipogenesis, and HBV replication are commonly regulated by PGC-1α-dependent pathway
Jhuang, H.-J., Hsu, W., Lin, K., Hsu, S., Wang, F., Chou, C., Lee, K., Tsou, A., Lai, J.-M., Yeh, S.-F., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3050 · Cited by 20
Skeletal Muscle Tissue Trib3 Links Obesity with Insulin Resistance by Autophagic Degradation of AKT2
Kwon, M., Eom, J., Kim, D., Kim, J., Heredia, J., Kang, S., & Song, Y. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000492264 · Cited by 20
Chiaranunt, P., Ferrara, J. L. M., & Byersdorfer, C. A. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.07.023 · Cited by 24
PGC-1α activation: a therapeutic target for type 2 diabetes?
Yuan, D., Xiao, D., Gao, Q., & Zeng, L. (2018) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-018-0622-y · Cited by 20
A critical role for hepatic protein arginine methyltransferase 1 isoform 2 in glycemic control
Ma, Y., Liu, S., Jun, H., Wang, J., Fan, X., Li, G., Yin, L., Rui, L., Weinman, S. A., Gong, J., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202001061r · Cited by 20
Wang, H., & Wang, J. (2013) · Cell Biology International · doi:10.1002/cbin.10148 · Cited by 19
Froy, O., Sherman, H., Bhargava, G., Chapnik, N., Cohen, R., Gutman, R., Kronfeld‐Schor, N., & Miskin, R. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.125 · Cited by 19
miR-696 plays a role in hepatic gluconeogenesis in ob/ob mice by targeting PGC-1α
Fang, Z., Li, P., Jia, W., Jiang, T., Wang, Z., & Xiang, Y. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2659 · Cited by 19
Jung, Y. S., Lee, J.-M., Kim, D., Lee, Y. S., Kim, K.-S., Kim, Y., Kim, J., Lee, M., Lee, I., Kim, S. H., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159425 · Cited by 18
Self-citationKonda, P. Y., Chennupati, V., Dasari, S., Sharma, R., Muthulingam, M., Ramakrishnan, R., Sade, A., Jagadheeshkumar, V., Vijayakumar, N., & Jaiswal, K. K. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113576 · Cited by 21
Hepatic Gadd45β promotes hyperglycemia and glucose intolerance through DNA demethylation of PGC-1α
Wu, L., Jiao, Y., Li, Y., Jiang, J., Zhao, L., Li, M., Li, B., Yan, Z., Chen, X., Li, X., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20201475 · Cited by 19
Lucchinetti, E., Lou, P., Holtzhauer, G., Noureddine, N., Wawrzyniak, P., Hartling, I., Lee, M., Strachan, E. R., Clemente‐Casares, X., Tsai, S. J., et al. (2022) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac272 · Cited by 19
TRB3 mediates homocysteine‐induced inhibition of endothelial cell proliferation
Zou, T., Liu, W., Li, S., Zhou, W., Yang, J., & Zou, C. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22554 · Cited by 17
“It has been shown that PPARa promotes TRB3 expression in liver in a PGC-1a-dependent manner (Koo et al., 2004).”
BackgroundChang, J. S., Jun, H., & Park, M. (2016) · Physiological Reports · doi:10.14814/phy2.13013 · Cited by 19
“Adenovirus-mediated PGC-1a knockdown and liverspecific PGC-1a knockout, which diminish both FL-PGC1a and NT-PGC-1a, greatly reduce fasting-induced gluconeogenic gene expression and hepatic glucose production (Koo et al. 2004; Handschin et al. 2005).”
BackgroundYao, Y., Voillet, V., Jégou, M., SanCristobal, M., Dou, S., Rome, V., Lippi, Y., Billon, Y., Pére, M.-C., Boudry, G., et al. (2017) · BMC Genomics · doi:10.1186/s12864-017-4001-2 · Cited by 26
Lee, H.-J., Su, Y., Lui, W., Chau, G., Yin, P., Lee, H., & Chi, C. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.01.033 · Cited by 17
Raza, G. S., Kaya, Y., Stenbäck, V., Sharma, R., Sodum, N., Mutt, S. J., Gagnon, D. D., Tulppo, M. P., Järvelin, M., Herzig, K., et al. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300465 · Cited by 17
Radhakrishnan, K., Kim, Y., Jung, Y. S., Kim, J., Kim, D., Cho, S. J., Lee, I., Dooley, S., Lee, C., & Choi, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197148 · Cited by 17
Self-citationSOX4 as biomarker in hepatitis B virus-associated hepatocellular carcinoma
Huang, J., Wang, X., Liao, X., Han, C., Yu, T., Huang, K., Yang, C., Liu, X., Yu, L., Zhu, G., et al. (2021) · Journal of Cancer · doi:10.7150/jca.46579 · Cited by 16
Circulating Bile Acid Profiles: A Need for Further Examination
Li, Q., Tian, Y., & Chen, Y. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab531 · Cited by 17
A Novel Function of Hepatic FOG2 in Insulin Sensitivity and Lipid Metabolism Through PPARα
Guo, Y., Yu, J., Deng, J., Liu, B., Xiao, Y., Li, K., Xiao, F., Yuan, F., Liu, Y., Chen, S., et al. (2016) · Diabetes · doi:10.2337/db15-1565 · Cited by 12
Yu, X. L., Huang, S., Deng, Q., Tang, Y., Yao, P., Tang, H., & Dong, X. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.12.016 · Cited by 16
Mazzoli, A., Gatto, C., Crescenzo, R., Cigliano, L., & Iossa, S. (2021) · Nutrients · doi:10.3390/nu13041370 · Cited by 18
Kim, J.-W., You, Y., Ham, D., Cho, J., Ko, S., Song, K., Son, H., Suh‐Kim, H., Lee, I. K., & Yoon, K. (2009) · Endocrinology · doi:10.1210/en.2009-0241 · Cited by 15
The Paradoxical Effects of AMPK on Insulin Gene Expression and Glucose‐Induced Insulin Secretion
Kim, J., You, Y., Ham, D., Yang, H. K., & Yoon, K. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25271 · Cited by 16
Metadata
- Authors
- Koo, S.-H., Satoh, H., Herzig, S., Lee, C.-H., Hedrick, S., Kulkarni, R., Evans, R. M., Olefsky, J., & Montminy, M.
- Affiliations
- Salk Institute for Biological Studies (US)
- University of California San Diego (US)
- Joslin Diabetes Center (US)
- Corresponding author
- Montminy, Marc
- ORCID
- Venue
- Nature Medicine
- Published
- 2004-04-25
- Volume
- 10
- Issue
- 5
- Pages
- 530-534
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1603786143
- Cited by
- 550
- References
- 28
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 10 · 2023: 9 · 2022: 15 · 2021: 19 · 2020: 19 · 2019: 13 · 2018: 22 · 2017: 20 · 2016: 21 · 2015: 22 · 2014: 34 · 2013: 31 · 2012: 31
- FWCI
- 16.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM037828, GM R01 37828)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- PGC-1, insulin resistance, PPARα, type 2 diabetes, hepatic insulin sensitivity, glucose tolerance, Akt signaling, fasting hypoglycemia, nuclear receptors, hepatic gluconeogenesis, RNAi knockdown
- MeSH terms
- Animals, Base Sequence, Diabetes Mellitus, Type 2, DNA, Humans, Insulin Resistance, Liver, Male, Mice, Inbred C57BL, Mice, Obese, Transcription Factors, Signal Transduction, Rats, Wistar, Receptors, Cytoplasmic and Nuclear, Mice, Knockout, Cell Cycle Proteins, RNA Interference, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.